Related Experiment Video
Updated: Jun 10, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Assessing changes in brain structure in new-onset children with acute lymphoblastic leukemia
Shu Su1, Hua-Qiong Qiu1, Lian-Hong Cai2
1Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
New-onset pediatric acute lymphoblastic leukemia (ALL) shows widespread brain structural abnormalities, indicating the disease itself causes injury before treatment. MRI can detect these early brain changes in children with ALL.
Area of Science:
- Neuroimaging
- Pediatric Oncology
- Radiology
Background:
- Brain structure injury is known after acute lymphoblastic leukemia (ALL) treatment.
- Alterations in new-onset pediatric ALL are not well understood.
Purpose of the Study:
- To explore white matter (WM) and grey matter (GM) alterations in new-onset pediatric ALL.
- Utilize surface-based morphometry (SBM) and tract-based spatial statistics (TBSS).
Main Methods:
- Recruited 35 pediatric ALL patients and 33 typically developing (TD) children.
- Acquired 3D T1-weighted and diffusion tensor imaging (DTI).
- Compared DTI metrics, cortical GM features, and deep GM nuclei volume between groups.
Main Results:
- Pediatric ALL showed decreased cortical surface area, thickness, and volume in several brain regions.
- Increased fractional anisotropy (FA) was noted in the corpus callosum and superior corona radiata.
- Reduced volumes were observed in bilateral thalamus, caudate, hippocampus, and right putamen.
Conclusions:
- New-onset pediatric ALL exhibits widespread brain structural abnormalities.
- These findings suggest the disease itself can cause brain structural injury prior to chemotherapy.
- MRI is a sensitive tool for early detection of brain damage in pediatric ALL.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018